Perspective Therapeutics (CATX) Receivables (2011 - 2026)
Perspective Therapeutics (CATX) posted Receivables of $58000.0 for Q1 2026, up 262.5% sequentially from $16000.0 in Q4 2025, and down 25.64% YoY from $78000.0 in Q1 2025.
Perspective Therapeutics (CATX) Receivables (2011 - 2026) Analysis & Trends
Perspective Therapeutics has reported Receivables for 16 years, with the latest figure at $58000.0 in Q1 2026.
- Quarterly Receivables fell 25.64% year-over-year to $58000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58000.0 (down 25.64% YoY) and the FY2025 annual result came in at $16000.0, down 97.35% from the prior year.
- Receivables grew to $58000.0 in Q1 2026 per CATX's latest filing, from $16000.0 in the prior quarter.
- Over five years, Receivables peaked at $2.1 million in Q1 2022 and troughed at $16000.0 in Q4 2025.
- A 5-year average of $837823.5 and a median of $999000.0 in 2024 frame the typical range for Receivables.
- The widest YoY moves for Receivables: up 58.45% in 2025, down 97.35% in 2025.
- Over 5 years, Receivables stood at $1.4 million in 2022, then fell by 13.92% to $1.2 million in 2023, then plunged by 48.68% to $603000.0 in 2024, then slumped by 97.35% to $16000.0 in 2025, then soared by 262.5% to $58000.0 in 2026.
- According to Business Quant data, Receivables over the past three periods registered $58000.0, $16000.0, and $179000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 3.74 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 3.18 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 955.70 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 1.28 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 4.66 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 4.12 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 1.01 Bn |
| 10 | Perspective Therapeutics | 384.27 Mn | 384.27 Mn | - | 269,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 269,000.00 |
| Mar 31, 2026 | 58,000.00 |
| Dec 31, 2025 | 16,000.00 |
| Sep 30, 2025 | 179,000.00 |
| Jun 30, 2025 | 225,000.00 |
| Mar 31, 2025 | 78,000.00 |
| Dec 31, 2024 | 603,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 142,000.00 |
| Mar 31, 2024 | 999,000.00 |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 1.73 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 1.37 Mn |
| Sep 30, 2022 | 1.21 Mn |
| Jun 30, 2022 | 1.63 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 1.65 Mn |
| Sep 30, 2021 | 1.90 Mn |